Evelyn Partners Investment Management LLP

Position in ARVN — Arvinas, Inc.

CIK 2065206 London, X0

Position in ARVN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,624

-$1,857 QoQ

Shares Held

1,474

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Evelyn Partners Investment Management LLP holds $149,476 across 6 Biotechnology names. ARVN ranks #3 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	1,300	$61,841
2	ALNY	Alnylam Pharmaceuticals, Inc.	175	$57,902
3	ARVN	Arvinas, Inc. This page	1,474	$15,624
4	ONC	BeOne Medicines Ltd.	41	$12,175
5	PRTA	Prothena Corp Public Ltd Co	199	$1,934
6			150	$0

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,624	1,474	0.0%	Shares	Sole	2026-05-15
2025-12-31	$17,481	1,474	0.0%	Shares	Sole	2026-02-13
2025-09-30	$12,558	1,474	0.0%	Shares	Sole	2025-11-14
2025-06-30	$10,848	1,474	0.0%	Shares	Sole	2025-11-26
2025-03-31	$10,347	1,474	0.0%	Shares	Sole	2025-12-08
2024-12-31	$28,256	1,474	—	Shares	Sole	2025-12-11
No filing history on record for this holder in this stock.